Related Experiment Video
Updated: Jun 12, 2026

08:22
Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay
Published on: February 23, 2020
ELISA-LOC: lab-on-a-chip for enzyme-linked immunodetection
Steven Sun1, Minghui Yang, Yordan Kostov
1Division of Biology, Office of Science and Engineering, FDA, Silver Spring, MD 20993, USA.
Lab on a Chip
|June 15, 2010
Summary
A novel lab-on-a-chip system enables Staphylococcal Enterotoxin B (SEB) detection without a laboratory. This point-of-care device uses microfluidics and enhanced biosensing for sensitive immunological assays.
Area of Science:
- Biotechnology
- Biosensor Technology
- Microfluidics
Background:
- Conventional immunoassays require laboratory settings and specialized equipment.
- Point-of-care diagnostics are crucial for rapid disease detection and management.
- Detection of foodborne pathogens like Staphylococcal Enterotoxin B (SEB) is critical for public health.
Purpose of the Study:
- To design, fabricate, and test a miniature 96-well ELISA lab-on-a-chip (ELISA-LOC) for immunological detection of SEB.
- To develop a portable, lab-free system for immunological assays.
- To integrate microfluidics, carbon nanotube technology, electrochemiluminescence, and CCD detection for enhanced sensitivity.
Main Methods:
- Fabrication of the ELISA-LOC using Laminated Object Manufacturing (LOM) with acrylic and polycarbonate layers.
- Integration of microfluidics with surface tension valves for reagent delivery and removal.
- Utilization of carbon nanotube (CNT) technology for antibody immobilization.
- Implementation of electrochemiluminescence (ECL) detection coupled with a charge-coupled device (CCD) detector.
Main Results:
- The ELISA-LOC successfully detected Staphylococcal Enterotoxin B (SEB) using a sandwich ELISA assay.
- Achieved a limit of detection as low as 0.1 ng/mL for SEB, comparable to conventional ELISA.
- Demonstrated a power-free, syringe-operated fluidics system for simplified assay execution.
- The system allows immunological assays to be performed outside of a traditional laboratory environment.
Conclusions:
- The developed ELISA-LOC is a viable point-of-care (POC) system for sensitive and rapid immunological detection of SEB.
- This technology offers a simplified approach to complex medical assays, eliminating the need for laboratory infrastructure.
- The integrated biosensing elements and microfluidics pave the way for broader applications in diagnostics.
Related Concept Videos
Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Enzyme-linked Receptors
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

